Screening and Characterization of Pediococcus acidilactici LC-9-1 toward Selection as a Potential Probiotic for Poultry with Antibacterial and Antioxidative Properties
- 2023-01-17
- Antioxidants 12(2)
- Chong Li
- Shaolong Wang
- Si Chen
- Xiaoying Wang
- Xuejuan Deng
- Guohua Liu
- Wenhuan Chang
- Y. Beckers
- Huiyi Cai
- PubMed: 36829774
- DOI: 10.3390/antiox12020215
Abstract
Growing interest has been focused on lactic acid bacteria as alternatives to antimicrobial growth promoters, which are characterized by the production of various functional metabolites, such as antimicrobial and antioxidants compounds. The present study was undertaken to evaluate a potential probiotic from the antioxidant perspective. LC-9-1, screened from the intestines of healthy animals, was revealed to be Pediococcus acidilactici on the basis of its morphological, biochemical, and molecular characteristics. The strain has excellent properties, including acid-production efficiency, antibacterial performance and antioxidant activity. The safety of the strain was also evaluated. Furthermore, the experiments in broiler chickens suggested that dietary LC-9-1 supplementation improved the growth performance and decreased the abdominal fat, and enhanced the antioxidant capability and intestinal innate immunity of broilers. Analysis of intestinal microbiota showed that a higher community diversity (Shannon index) was achieved. In addition to the significantly increased relative abundances of Pediococcus spp., beneficial genera such as Rothia spp. and Ruminococcus spp. were abundant, while opportunistic pathogens such as Escherichia-Shigella spp. were significantly reduced in LC-9-1-supplemented broilers. Collectively, such in-depth characterization and the available data will guide future efforts to develop next-generation probiotics, and LC-9-1 could be considered a potential strain for further utilization in direct-fed microbial or starter culture for fermentation.
Keywords: Pediococcus acidilactici; antibacterial; antioxidant; broiler chickens; intestinal microbiota; screening.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Pediococcus acidilactici | Improved Antioxidant Function | Beneficial | Moderate |
Pediococcus acidilactici | Improved Community Diversity of Intestinal Microbiota | Beneficial | Moderate |
Pediococcus acidilactici | Improved Growth Performance | Beneficial | Large |
Pediococcus acidilactici | Increased Beneficial Gut Bacteria | Beneficial | Moderate |
Pediococcus acidilactici | Reduced Abdominal Fat | Beneficial | Moderate |
Pediococcus acidilactici | Reduced Opportunistic Pathogens | Beneficial | Moderate |
Pediococcus acidilactici KABP™-021 | Improved Abundance of Beneficial Bacteria | Beneficial | Moderate |
Pediococcus acidilactici KABP™-021 | Improved Antioxidant Function | Beneficial | Moderate |
Pediococcus acidilactici KABP™-021 | Improved Gut Microbiota Diversity | Beneficial | Moderate |
Pediococcus acidilactici KABP™-021 | Improved Intestinal Innate Immunity | Beneficial | Moderate |
Pediococcus acidilactici KABP™-021 | Reduced Abdominal Fat | Beneficial | Moderate |
Pediococcus acidilactici KABP™-021 | Reduced Opportunistic Pathogens | Beneficial | Moderate |
Pediococcus acidilactici MAK92P26A | Improved Antioxidant Function | Beneficial | Moderate |
Pediococcus acidilactici MAK92P26A | Improved Gut Microbiota Diversity | Beneficial | Moderate |
Pediococcus acidilactici MAK92P26A | Improved Intestinal Innate Immunity | Beneficial | Moderate |
Pediococcus acidilactici MAK92P26A | Increased Beneficial Gut Bacteria | Beneficial | Moderate |
Pediococcus acidilactici MAK92P26A | Reduced Abdominal Fat | Beneficial | Moderate |
Pediococcus acidilactici MAK92P26A | Reduced Opportunistic Pathogens | Beneficial | Moderate |
Pediococcus acidilactici R1001 | Improved Antioxidant Function | Beneficial | Moderate |
Pediococcus acidilactici R1001 | Improved Growth Performance | Beneficial | Large |
Pediococcus acidilactici R1001 | Improved Gut Microbiota Diversity | Beneficial | Moderate |
Pediococcus acidilactici R1001 | Improved Intestinal Immunity | Beneficial | Moderate |
Pediococcus acidilactici R1001 | Increased Beneficial Gut Bacteria | Beneficial | Moderate |
Pediococcus acidilactici R1001 | Reduced Abdominal Fat | Beneficial | Moderate |
Pediococcus acidilactici R1001 | Reduced Opportunistic Pathogens | Beneficial | Moderate |
Pediococcus acidilactici VPro29 | Improved Antioxidant Function | Beneficial | Moderate |
Pediococcus acidilactici VPro29 | Improved Growth Performance | Beneficial | Large |
Pediococcus acidilactici VPro29 | Improved Gut Microbiota Diversity | Beneficial | Moderate |
Pediococcus acidilactici VPro29 | Improved Intestinal Innate Immunity | Beneficial | Moderate |
Pediococcus acidilactici VPro29 | Increased Gut Microbiota Abundance | Beneficial | Moderate |
Pediococcus acidilactici VPro29 | Reduced Abdominal Fat | Beneficial | Moderate |
Pediococcus acidilactici VPro29 | Reduced Pathogen Infection | Beneficial | Moderate |